BioCentury (June 29, 2017)
Read MoreBioWorld Medtech (June 29, 2017)
Read MoreAngewandte Chemie (April 29, 2015)
Read MoreGenomeWeb | Dec 19, 2014 | Adam Bonislawski
“As we have talked to pharmaceutical companies, it has become very clear that their interest is in super-binding molecules that can target very low abundance therapeutic targets, things that are really hard to reach with a monoclonal,” said
Dr. Doug Fisher, to Speak at Life Sciences Summit
October 29, 2014 | New York, NY | www.lifesciencessummit.org
BioCentury | 31 March 2014 | Emily Cukier-Meisner
“We’ve been able to create a completely synthetic approach to building binding
molecules,” said Albert Luderer, CEO
Puget Sound Business Journal | 4 January 2013 |
Patti Payne “Dr. Leroy ‘Lee’ Hood, co-founder and president of the Seattle-based Institute for Systems Biology, has been chosen to receive the highest award bestowed upon scientists by the United States government: the National Medal of Science.” Full Article [subscription required]
Xconomy | 13 June 2012 |
Luke Timmerman “This is like going from black and white with no sound to Technicolor and surround sound. It’s big.” Dr. Albert A Luderer, CEO, Integrated Diagnostics.
Technology Review | 22 February 2012 | Full Article
Read MoreProteoMonitor / GenomeWeb | 23 December 2011 | Adam Bonislawski [subscription required]
Read MoreProteoMonitor / GenomeWeb | 28 October 2011 | Adam Bonislawski[subscription required]
Integrated Diagnostics Taking Aim at In Vivo Imaging, Therapeutics Markets with New PCC Reagents
Read More